Galderma Differen adapalene gel Rx acne treatment planned to compete with Retin-A.
This article was originally published in The Tan Sheet
Executive Summary
GALDERMA HAS NDA PENDING FOR Rx DIFFEREN (ADAPALENE .1%) ACNE GEL, a naphtholic acid derivative that has "potent retinoid and anti- inflammatory properties," according to Ft. Worth, Tex.-based Galderma Labs. Once approved, Differen will compete with Ortho Pharmaceutical's prescription acne treatment, Retin-A.